Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2018-2033)
2.2 Crohn’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Crohn’s Disease Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Crohn’s Disease Therapeutics Market Dynamics
2.3.1 Crohn’s Disease Therapeutics Industry Trends
2.3.2 Crohn’s Disease Therapeutics Market Drivers
2.3.3 Crohn’s Disease Therapeutics Market Challenges
2.3.4 Crohn’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2022
3.5 Crohn’s Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Crohn’s Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Crohn’s Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2024-2033)
5 Crohn’s Disease Therapeutics Breakdown Data by Application
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2018-2033)
6.2 North America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Crohn’s Disease Therapeutics Market Size by Country (2018-2023)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2018-2033)
7.2 Europe Crohn’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country (2018-2023)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Therapeutics Market Size (2018-2033)
9.2 Latin America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Crohn’s Disease Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Crohn’s Disease Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Detail
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Detail
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Detail
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Detail
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Detail
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Detail
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Detail
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Detail
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Detail
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Detail
11.11.2 Genentech Inc. Business Overview
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
11.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Detail
11.12.2 UCB India Private Limited. Business Overview
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
11.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2018-2023)
11.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Non-Surgical
Table 3. Key Players of Surgical
Table 4. Global Crohn’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Crohn’s Disease Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Crohn’s Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Crohn’s Disease Therapeutics Market Share by Region (2018-2023)
Table 8. Global Crohn’s Disease Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Crohn’s Disease Therapeutics Market Share by Region (2024-2033)
Table 10. Crohn’s Disease Therapeutics Market Trends
Table 11. Crohn’s Disease Therapeutics Market Drivers
Table 12. Crohn’s Disease Therapeutics Market Challenges
Table 13. Crohn’s Disease Therapeutics Market Restraints
Table 14. Global Crohn’s Disease Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Crohn’s Disease Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2022)
Table 17. Ranking of Global Top Crohn’s Disease Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Crohn’s Disease Therapeutics Product Solution and Service
Table 21. Date of Enter into Crohn’s Disease Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2024-2033)
Table 27. Global Crohn’s Disease Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2024-2033)
Table 31. North America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Crohn’s Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Crohn’s Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Crohn’s Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Crohn’s Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Crohn’s Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Crohn’s Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Johnson and Johnson Services Inc. Company Detail
Table 47. Johnson and Johnson Services Inc. Business Overview
Table 48. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product
Table 49. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Johnson and Johnson Services Inc. Recent Development
Table 51. Pfizer Inc. Company Detail
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Crohn’s Disease Therapeutics Product
Table 54. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Allergan Company Detail
Table 57. Allergan Business Overview
Table 58. Allergan Crohn’s Disease Therapeutics Product
Table 59. Allergan Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. AbbVie Inc. Company Detail
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. Crohn’s Disease Therapeutics Product
Table 64. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. Takeda Pharmaceutical Company Limited Company Detail
Table 67. Takeda Pharmaceutical Company Limited Business Overview
Table 68. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product
Table 69. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Takeda Pharmaceutical Company Limited Recent Development
Table 71. Celgene Corporation Company Detail
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Crohn’s Disease Therapeutics Product
Table 74. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Perrigo Company PLC Company Detail
Table 77. Perrigo Company PLC Business Overview
Table 78. Perrigo Company PLC Crohn’s Disease Therapeutics Product
Table 79. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Perrigo Company PLC Recent Development
Table 81. Ferring B.V. Company Detail
Table 82. Ferring B.V. Business Overview
Table 83. Ferring B.V. Crohn’s Disease Therapeutics Product
Table 84. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Ferring B.V. Recent Development
Table 86. Salix Pharmaceuticals Company Detail
Table 87. Salix Pharmaceuticals Business Overview
Table 88. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product
Table 89. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Salix Pharmaceuticals Recent Development
Table 91. Gilead Sciences Inc. Company Detail
Table 92. Gilead Sciences Inc. Business Overview
Table 93. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product
Table 94. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Gilead Sciences Inc. Recent Development
Table 96. Genentech Inc. Company Detail
Table 97. Genentech Inc. Business Overview
Table 98. Genentech Inc. Crohn’s Disease Therapeutics Product
Table 99. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Genentech Inc. Recent Development
Table 101. UCB India Private Limited. Company Detail
Table 102. UCB India Private Limited. Business Overview
Table 103. UCB India Private Limited. Crohn’s Disease Therapeutics Product
Table 104. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2018-2023) & (US$ Million)
Table 105. UCB India Private Limited. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn’s Disease Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Crohn’s Disease Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Non-Surgical Features
Figure 4. Surgical Features
Figure 5. Global Crohn’s Disease Therapeutics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Crohn’s Disease Therapeutics Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Crohn’s Disease Therapeutics Report Years Considered
Figure 10. Global Crohn’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Crohn’s Disease Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Crohn’s Disease Therapeutics Market Share by Region: 2022 VS 2033
Figure 13. Global Crohn’s Disease Therapeutics Market Share by Players in 2022
Figure 14. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Crohn’s Disease Therapeutics Revenue in 2022
Figure 16. North America Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Crohn’s Disease Therapeutics Market Share by Country (2018-2033)
Figure 18. United States Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Crohn’s Disease Therapeutics Market Share by Country (2018-2033)
Figure 22. Germany Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Crohn’s Disease Therapeutics Market Share by Region (2018-2033)
Figure 30. China Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Crohn’s Disease Therapeutics Market Share by Country (2018-2033)
Figure 38. Mexico Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Crohn’s Disease Therapeutics Market Share by Country (2018-2033)
Figure 42. Turkey Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Crohn’s Disease Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 45. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 46. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 47. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 48. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 49. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 50. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 51. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 52. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 53. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 54. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 55. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed